CI INVESTMENTS INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
CI INVESTMENTS INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$114
-4.2%
2,524
-13.2%
0.00%0.0%
Q2 2023$119
+176.7%
2,908
+141.7%
0.00%
Q1 2023$43
+437.5%
1,203
+495.5%
0.00%
Q4 2022$8202
+2425.0%
0.00%
Q3 2022$080.0%0.00%
Q2 2022$080.0%0.00%
Q1 2022$080.0%0.00%
Q4 2021$080.0%0.00%
Q3 2021$080.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders